Short Duration Alagebrium Chloride Therapy Prediabetes Does Not Inhibit Progression to Autoimmune Diabetes in an Experimental Model

Authors: Danielle J. Borg, Pouya Faridi, Kai Lin Giam, Peta Reeves, Amelia K. Fotheringham, Domenica A. McCarthy, Sherman Leung, Micheal S. Ward, Brooke E. Harcourt, Rochelle Ayala, Jean L. Scheijen, David Briskey, Nadine L. Dudek, Casper G. Schalkwijk, Raymond Steptoe, Anthony W. Purcell, Josephine M. Forbes

Source: Metabolites, Vol 11, Iss 7, p 426 (2021)

Subject Terms: advanced glycation end products, alagebrium chloride, cross-link breaker, immunopeptidome, MIN6N8 cell line, NOD mouse, Microbiology, QR1-502

File Description: electronic resource

Relation: https://www.mdpi.com/2218-1989/11/7/426; https://doaj.org/toc/2218-1989

Access URL: https://doaj.org/article/aa01d89ace73484cadb792438502955d

This result is not displayed to guests.
Login for full access.